Physicochemical Properties
| Molecular Formula | C30H62 |
| Molecular Weight | 422.81328 |
| Exact Mass | 422.485 |
| CAS # | 111-01-3 |
| Related CAS # | Squalane-d62;16514-83-3 |
| PubChem CID | 8089 |
| Appearance | Colorless to light yellow liquid |
| Density | 0.8±0.1 g/cm3 |
| Boiling Point | 470.3±0.0 °C at 760 mmHg |
| Melting Point | −38 °C(lit.) |
| Flash Point | 217.8±0.0 °C |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.448 |
| LogP | 15.59 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 21 |
| Heavy Atom Count | 30 |
| Complexity | 308 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C |
| InChi Key | PRAKJMSDJKAYCZ-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C30H62/c1-25(2)15-11-19-29(7)23-13-21-27(5)17-9-10-18-28(6)22-14-24-30(8)20-12-16-26(3)4/h25-30H,9-24H2,1-8H3 |
| Chemical Name | 2,6,10,15,19,23-hexamethyltetracosane |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Squalane exhibits significant promise for the pharmaceutical and nutraceutical sectors. In vitro and animal models, squalane has been shown to exhibit anticancer, antioxidant, drug carrier, detoxifying, skin moisturizing, and emollient properties [1]. |
| References |
[1]. Biological importance and applications of squalene and squalane. Adv Food Nutr Res. 2012;65:223-33. |
| Additional Infomation | Squalane has been reported in Murraya paniculata with data available. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~236.50 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.91 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (5.91 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (5.91 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.3651 mL | 11.8256 mL | 23.6513 mL | |
| 5 mM | 0.4730 mL | 2.3651 mL | 4.7303 mL | |
| 10 mM | 0.2365 mL | 1.1826 mL | 2.3651 mL |